GENinCode PLC - biotechnology company focused on prevention of cardiovascular disease - Raises £4.0 million via a placing and subscription, announced earlier Thursday, at the issue price of 5 pence per share. The issue price represents a discount of 7.1% to the closing middle market price of 5.38p on December 20, the last business day prior to the announcement of the fundraising. The placing was undertaken through an accelerated bookbuild process. A further announcement will be made on December 28 announcing the result of the retail offer under which the company aims to raise up to £1.0 million via Bookbuild to existing retail shareholders.

Current stock price: 5.63 pence, closed 4.7% higher on Thursday

12-month change: down 34%

Copyright 2023 Alliance News Ltd. All Rights Reserved.